Ac-225-DOTATOC – an empiric dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumors
There are no established dosimetry tools to predict toxicity of “targeted alpha-therapy” (TAT), yet. We conducted an empiric dose escalation to find the maximum tolerable dose (MTD) of single cycle and fractionation concepts for Ac-225-DOTATOC radionuclide therapy.
KRATOCHWIL Clemens;
BRUCHERTSEIFER Frank;
GIESEL Frederik;
APOSTOLIDIS Christos;
HABERKORN Uwe;
MORGENSTERN Alfred;
2015-07-13
SOC NUCLEAR MEDICINE INC
JRC94665
0161-5505,
Additional supporting files
| File name | Description | File type | |
|---|
